Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Penn researchers develop open-source software to infer evolutionary track of tumor metastasis

Individual cells within a tumor are not all the same. This may sound like a modern medical truism, but it wasn't very long ago that oncologists assumed that taking a single biopsy from a patient's tumor would be an accurate reflection of the physiological and genetic make-up of the entire mass.

9 Sep 2016

New drug holds potential for treating advanced mastocytosis

Most people have never heard of mastocytosis. It's a rare, sometimes deadly, immune disorder. Now new research may help those with advanced mastocytosis and possibly many more people, too.

6 Sep 2016

Oral contraceptive use may be reason for decline in mortality from ovarian cancer worldwide

Deaths from ovarian cancer fell worldwide between 2002 and 2012 and are predicted to continue to decline in the USA, European Union and, though to a smaller degree, in Japan by 2020, according to new research published in the leading cancer journal Annals of Oncology today (Tuesday).

5 Sep 2016

DNA-binding protein CHD1 could be potential biomarker for targeted prostate cancer treatment

The loss of CHD1, one of the most frequently mutated genes in prostate tumors, sensitizes human prostate cancer cells to different drugs, including PARP inhibitors.

5 Sep 2016

New NCCN Imaging AUC released for eight new cancers

The National Comprehensive Cancer Network, a Centers for Medicare & Medicaid Services-approved provider-led entity for imaging appropriate use criteria, continues to build its library of AUC and has published NCCN Imaging Appropriate Use Criteria for eight new cancer types. Launched in June 2016, NCCN Imaging AUC currently are available for 20 cancer types.

29 Aug 2016

New drug delivery system slows and controls tumors not aiming for complete elimination

Researchers have created a new drug delivery system that could improve the effectiveness of an emerging concept in cancer treatment - to dramatically slow and control tumors on a long-term, sustained basis, not necessarily aiming for their complete elimination.

26 Aug 2016

SGO and ASCO release clinical practice guidelines on ovarian cancer treatment

This week the Society of Gynecologic Oncology and the American Society of Clinical Oncology issued a joint clinical practice guideline on ovarian cancer treatment.

12 Aug 2016

Researchers develop computational algorithm to analyze big genomic data for different cancers

University of Hawai'i Cancer Center researchers developed a computational algorithm to analyze "Big Data" obtained from tumor samples to better understand and treat cancer.

10 Aug 2016

People diagnosed with bowel cancer under 50 not tested for Lynch syndrome, research finds

The UK’s leading bowel cancer research charity, Bowel Cancer UK, and the Royal College of Pathologists have today published findings which show that people under 50 diagnosed with bowel cancer are not being tested for Lynch syndrome – a genetic condition that increases the risk of bowel cancer by 80 per cent.

8 Aug 2016

Higher socioeconomic status linked to lower ovarian cancer risk in African American women

Higher socioeconomic status (SES) is associated with lower ovarian cancer risk in African American women, according to the results of a study by investigators at the Medical University of South Carolina and elsewhere reported online August 3 by the American Journal of Epidemiology.

4 Aug 2016

Brazilian study discovers promising therapeutic and diagnostic target for treatment of melanoma

A Brazilian study shows that inhibition of an RNA named RMEL3, which is encoded by a previously uncharacterized gene (also named RMEL3), can reduce the viability of cultured melanoma cells by up to 95%.

4 Aug 2016

Rice University bioengineer receives NIH grant to study use of AAV-based therapy to combat ovarian cancer

Rice University bioengineer Junghae Suh has been awarded a prestigious R01 grant by the National Institutes of Health to research the use of viral gene therapy to fight ovarian cancer.

3 Aug 2016

Bio-Rad expands product line by launching two human recombinant antigens

Bio-Rad Laboratories, Inc., a global provider of life science research and clinical diagnostic products, today announced the launch of two human recombinant antigens, expanding the company's portfolio of Critical Raw Materials for the in vitro diagnostics market.

1 Aug 2016

Collaborative effort to assist injured women with ovarian cancer from talc-based Baby Powder

Greg Vigna, MD, JD, founder of Life Care Solutions Group and Jane Akre, founder of Mesh Medical Device News Desk today launch a collaborative effort to educate, empower, and assist catastrophically injured women with ovarian cancer, who were exposed to Johnson & Johnson Baby Powder containing Talc.

30 Jul 2016

T-cell technology could be used to treat ovarian tumors with no adverse effects

With only incremental improvements in ovarian cancer survival over the last 40 years, there is a clear need for new treatment options with long-lasting results. Many researchers have turned toward the development of immunotherapies that direct T-cells to selectively eliminate ovarian tumor cells, but an appropriate therapeutic target for ovarian cancers has remained elusive.

29 Jul 2016

Researchers develop tiny 3-D tissue models to study how ovarian cancer develops in women

With a unique approach that draws on 3-D printing technologies, a team of University of Wisconsin-Madison researchers is developing new tools for understanding how ovarian cancer develops in women.

27 Jul 2016

Study uncovers new drug-gene mutation combinations that can kill cancer cells

In an effort to expand the number of cancer gene mutations that can be specifically targeted with personalized therapies, researchers at University of California San Diego School of Medicine and Moores Cancer Center looked for combinations of mutated genes and drugs that together kill cancer cells.

22 Jul 2016

Scientists find promising new method to detect and treat recurrence of ovarian cancer

Researchers at the Mayo Clinic Center for Individualized Medicine have found a promising new way to monitor and treat recurrence of ovarian cancer -- a hard-to-detect disease that claims many lives.

21 Jul 2016

New streamlined approach to genetic testing benefits women with ovarian cancer

A new streamlined approach to genetic testing for women with ovarian cancer provides testing rapidly and affordably, allowing many more patients to benefit from personalised cancer management and their relatives to benefit from cancer prevention strategies.

13 Jul 2016

Study shows feasibility to adopt salpingectomy in large scale clinical practice without surgical repercussions

A surgical procedure recommended to reduce the future risk of ovarian cancer has been successfully implemented throughout Kaiser Permanente in Northern California without a change in surgical outcomes, according to research published today in the journal Obstetrics & Gynecology.

12 Jul 2016

Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Penn researchers develop open-source software to infer evolutionary track of tumor metastasis

New drug holds potential for treating advanced mastocytosis

Oral contraceptive use may be reason for decline in mortality from ovarian cancer worldwide

DNA-binding protein CHD1 could be potential biomarker for targeted prostate cancer treatment

New NCCN Imaging AUC released for eight new cancers

New drug delivery system slows and controls tumors not aiming for complete elimination

SGO and ASCO release clinical practice guidelines on ovarian cancer treatment

Researchers develop computational algorithm to analyze big genomic data for different cancers

People diagnosed with bowel cancer under 50 not tested for Lynch syndrome, research finds

Higher socioeconomic status linked to lower ovarian cancer risk in African American women

Brazilian study discovers promising therapeutic and diagnostic target for treatment of melanoma

Rice University bioengineer receives NIH grant to study use of AAV-based therapy to combat ovarian cancer

Bio-Rad expands product line by launching two human recombinant antigens

Collaborative effort to assist injured women with ovarian cancer from talc-based Baby Powder

T-cell technology could be used to treat ovarian tumors with no adverse effects

Researchers develop tiny 3-D tissue models to study how ovarian cancer develops in women

Study uncovers new drug-gene mutation combinations that can kill cancer cells

Scientists find promising new method to detect and treat recurrence of ovarian cancer

New streamlined approach to genetic testing benefits women with ovarian cancer

Study shows feasibility to adopt salpingectomy in large scale clinical practice without surgical repercussions

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in